Valuation: Boule Diagnostics AB

Market Cap 49.51M 4.86M 4.43M 4.1M 3.7M 6.97M 454M 7.24M 19.57M 245M 18.24M 17.86M 774M P/E 2026 *
-5.07x
P/E 2027 * 5.76x
Enterprise Value 246M 24.16M 22.03M 20.37M 18.39M 34.63M 2.26B 35.99M 97.26M 1.22B 90.64M 88.74M 3.85B EV / Sales 2026 *
0.54x
EV / Sales 2027 * 0.48x
Free-Float
64.69%
Yield 2026 *
-
Yield 2027 * -
1 day-5.49%
1 week-3.21%
Current month+16.43%
1 month-42.07%
3 months-63.48%
6 months-63.48%
Current year-75.46%
1 week 1.14
Extreme 1.145
1.44
1 month 0.84
Extreme 0.84
2.2
Current year 0.84
Extreme 0.84
5.68
1 year 0.84
Extreme 0.84
6.26
3 years 0.84
Extreme 0.84
12.62
5 years 0.84
Extreme 0.84
59.5
10 years 0.84
Extreme 0.84
108.88
Manager TitleAgeSince
Chief Executive Officer - 22/06/2026
Director of Finance/CFO 54 11/02/2026
Chief Tech/Sci/R&D Officer - 01/01/2019
Director TitleAgeSince
Director/Board Member 59 01/01/2014
Chairman 73 01/01/2021
Chairman 74 01/01/2023
Date Insider Type Main position Quantity % Market Cap. Importance
27/2/23 Buy

Chief Financial Officer

8,000 0.0206%
6/2/23 Buy

Director

7,083 0.0182%
17/2/22 Buy

Director

2,000 0.0103%
Change 5-day change 1-year change 3-year change Capi.($)
-5.49%-3.21%-78.01%-87.83% 4.9M
+0.43%-3.80%+19.86%+47.20% 254B
+0.92%-3.21%+0.99%+7.92% 159B
-1.41%-5.67%-22.44%+36.21% 149B
+1.20%-3.56%-56.13%-20.08% 62.37B
-0.15%-0.82%+24.87%+56.18% 60.62B
+1.25%+0.74%+5.46%-12.32% 53.05B
+2.17%-0.54%+22.35%+54.40% 48.55B
-3.53%-8.82%+1.52%+55.49% 46.7B
+2.82%-1.46%+23.20%+77.83% 44.21B
Average -0.18%-1.92%-5.83%+21.50% 88B
Weighted average by Cap. +0.27%-2.99%+2.66%+32.85%

Financials

2026 *2027 *
Net sales 453M 44.49M 40.58M 37.52M 33.86M 63.77M 4.16B 66.28M 179M 2.24B 167M 163M 7.09B 483M 47.46M 43.28M 40.02M 36.12M 68.02M 4.43B 70.7M 191M 2.39B 178M 174M 7.56B
Net income -9.77M -960K -875K -809K -730K -1.38M -89.68M -1.43M -3.86M -48.4M -3.6M -3.52M -153M 8.6M 844K 770K 712K 642K 1.21M 78.88M 1.26M 3.4M 42.57M 3.17M 3.1M 134M
Net Debt 197M 19.3M 17.6M 16.27M 14.69M 27.66M 1.8B 28.75M 77.69M 973M 72.4M 70.89M 3.07B 185M 18.12M 16.52M 15.28M 13.79M 25.97M 1.69B 26.99M 72.94M 914M 67.97M 66.55M 2.89B
Projected Income Statement - Annual - Boule Diagnostics AB
Logo Boule Diagnostics AB
Boule Diagnostics AB is a Sweden-based company engaged in the provision of medical diagnostic and testing equipment. The Company specializes in the development, manufacture and sale of complete blood count (CBC) systems in the field of hematology. It provides reagents, cleaning products and blood calibrators and controls that are used in human and veterinarian laboratories, as well as analyzers and complementing accessories for hematology systems. The Company’s product portfolio comprises five brands: Clinical Diagnostic Solutions, Exigo, Medonic, Swelab and Quintus. The Company’s primary customer base comprises small and medium-sized hospitals, clinics, diagnostics firms and laboratories. Furthermore, It operates worldwide through a number of subsidiaries, such as Boule Medical AB, Boule Nordic AB, Clinical Diagnostic Solutions Inc and Boule Medical (Beijing) Co Ltd.
Employees
200
Date Price Change Volume
19/11/26 SEK 1.205 -5.49% 472,336
17/11/26 SEK 1.275 0.00% 74,948
16/11/26 SEK 1.275 +2.41% 589,621
13/11/26 SEK 1.245 -10.43% 535,012
12/11/26 SEK 1.390 +11.65% 293,768
Trader
-
Investor
-
Global
-
Quality
-
ESG MSCI
A
MarketScreener Ratings - Boule Diagnostics AB
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
1
Last Close Price
1.275SEK
Average target price
3.800SEK
Spread / Average Target
+198.04%
  1. Stock Market
  2. Stocks
  3. BOUL Stock